Fundraising FoxArkis BioSciences
Knoxville, US · Founded 2016 · Delaware corporation · 1 known investors
Find your way into Arkis BioSciences
Sign up to see every warm intro you have to Arkis BioSciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arkis BioSciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Medical device company for neurosurgical treatment of intracranial hypertension. Acquired in 2019.
Founders & leadership
QA
Quentin AtenNamed on SEC filing
JA
James A. Killeffer, M.D.Named on SEC filing
KW
CE
Chad E. SeaverNamed on SEC filing
CM
Clif MoyersNamed on SEC filing
SA
Stephen ArnoldNamed on SEC filing
Investors · 1
Innova Memphis, Inc.listed by Innova Memphis, Inc.Memphis · $2M
How we know: Innova Memphis, Inc.'s portfolio page · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$7.8M disclosed across 2 rounds · 2016–2018
▶$3.4MraisedAug 2018 · 8 investors · BiotechnologyRule 506(b)
▶$3.4MraisedAug 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chad E. SeaverExecutive Officer, Director
- Ken WoodyDirector
- Quentin AtenExecutive Officer
- Clif MoyersDirector
- Stephen ArnoldExecutive Officer
- James A. Killeffer, M.D.Executive Officer, Director
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$4.5MraisedAug 2018 · 25 investors · BiotechnologyRule 506(b)
▶$4.5MraisedAug 2018 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Quentin AtenExecutive Officer
- James A. Killeffer, M.D.Executive Officer, Director
- Ken WoodyDirector
- Chad E. SeaverExecutive Officer, Director
- Clif MoyersDirector
- Stephen ArnoldExecutive Officer
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Arkis BioSciences do?
- Medical device company for neurosurgical treatment of intracranial hypertension. Acquired in 2019.
- Who are Arkis BioSciences's investors?
- Arkis BioSciences's investors include Innova Memphis, Inc..
- How much funding has Arkis BioSciences raised?
- Arkis BioSciences has disclosed $7.8M raised across 2 rounds.
- Where is Arkis BioSciences headquartered?
- Arkis BioSciences is headquartered in Knoxville, US.